CGC-602

N/A

Report date: 2025/02/13 16:49:27

Base Information

Drug NameCGC-602
Drug Alias NameCGC-602
ClassificationBiologics
Mechanisms of ActionProgrammed cell death protein 1 modulatorsInterleukin-2 modulators
TargetsProgrammed cell death protein 1Interleukin-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Cure Genetics Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Cure Genetics Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A